NanoLogix technology is used to design and market diagnostic test kits for
use in early detection of bacteria and other microorganisms present in infectious
and noninfectious human diseases, the environment, industrial and manufacturing
settings, veterinary medicine, and research and testing laboratories.
NanoLogix began 20 years ago under the name Infectech. The company has been
issued 33 patents applicable in the areas of applied microbiology, soil microbiology,
medical diagnostics, microbial physiology, molecular biology, pharmacology,
pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and hydrogen
generation through use of bioreactors.
In 2007 the focus of the company evolved from pure Research and Development
to capitalizing on the company's intellectual property through a transition
to production of BNP™ Ultra-Fast diagnostic test kits and their marketing.